This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

LifeTech Industries Appoints Dr. Abhimanyu Uberoi To Its Advisory Board

Stocks in this article: LTCH

PALO ALTO, Calif., Dec. 11, 2012 /PRNewswire/ -- LifeTech Industries Inc. (OTCBB:  LTCH) announced today the appointment of Dr. Abhimanyu Uberoi to the Company's international advisory board.  Dr. Uberoi is currently serving as a cardiology fellow at Cedars-Sinai Hospital in Los Angeles, California.

Dr. Uberoi has cultivated an interest in global health and has made frequent trips to Ensenada, Tijuana, Tecate and other Mexican border town clinics as a volunteer to provide medical care to the less fortunate.  He has also participated in medical missions to the Indo-Tibetan borderlands in the Himalayas as well as a medical-environmental conservational mission in the rainforests of Borneo, Indonesia.  As his experience grows, his dedication to serving these marginalized and underserved communities has also grown.

"Dr. Uberoi provides significant value by providing us with valuable insight to help LifeTech customize our products to help a wider range of people," said Benjamin Chung, President and CEO of LifeTech Industries.  "His in-depth knowledge of the global health market offers us a competitive advantage in further developing our brand."

CONTACT PERSON:

Benjamin ChungLifeTech Industries1-888-271-9368 ir@lifetechindustries.com

SOURCE LifeTech Industries Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs